Hormonal profile of menopausal women receiving androgen replacement therapy: a meta-analysis

Published on Feb 3, 2020in Journal of Endocrinological Investigation3.439
· DOI :10.1007/S40618-020-01192-X
Ljiljana Marina4
Estimated H-index: 4
Antoan Stefan Sojat + 3 AuthorsDaniele Santi16
Estimated H-index: 16
Ovarian and adrenal aging leads to a progressive decline in androgen levels and deleterious effects on the quality of life. Despite this, specific replacement is not routinely recommended in the management of women with a physiological or pathological decline in their production, mainly due to the lack of long-term follow-up safety data. The purpose of this paper was to meta-analyze and summarize the existing data about hormonal profile changes in menopausal women receiving androgen replacement treatments. Full-text articles published through May 30, 2018 were found via MEDLINE and Embase and selected according to the strict inclusion criteria. Randomized clinical trials and case–control studies were enrolled. Studies not reporting steroid serum levels or not providing a control group were excluded from the analysis. Studies enrolling women with genetic defects or severe chronic systemic diseases were excluded. 113 papers fulfilled the inclusion criteria and 56 papers were included in the analysis. Desired data were compiled and extracted by independent observers. Androgen administration increases E1, E2, testosterone, DHEA and DHEAS serum levels, and reduces SHBG. However, the E1 and E2 increase is evident only when DHEA is administered. Whatever androgen formulation we choose in postmenopausal women, the end result is a rise in testosterone serum levels. However, DHEA regimen is also associated with an increased estrogenic availability. This might be crucial when choosing the best possible treatment for each patient individually taking into consideration if potential benefits outweigh the risks.
  • References (43)
  • Citations (0)
📖 Papers frequently viewed together
1 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Susan R. Davis (Monash University)H-Index: 68
#2Rod Baber (USYD: University of Sydney)H-Index: 21
Last. Margaret E. Wierman (Anschutz Medical Campus)H-Index: 41
view all 16 authors...
This Position Statement has been endorsed by the International Menopause Society, The Endocrine Society, The European Menopause and Andropause Society, The International Society for Sexual Medicine, The International Society for the Study of Women's Sexual Health, The North American Menopause Society, The Federacion Latinoamericana de Sociedades de Climaterio y Menopausia, The Royal College of Obstetricians and Gynecologists, The International Society of Endocrinology, The Endocrine Society of A...
6 CitationsSource
#1Andrea Giannini (UniPi: University of Pisa)H-Index: 9
#2Ar Genazzani (University of Modena and Reggio Emilia)H-Index: 26
Last. Andrea R. Genazzani (UniPi: University of Pisa)H-Index: 66
view all 7 authors...
Abstracts-endorphin is a neuropeptide involved in several brain functions: its plasma levels are higher in obese women and its release increases after oral glucose tolerance test (OGTT) in normal o...
#1Rakibul M. Islam (Monash University)H-Index: 7
#2Robin J. Bell (Monash University)H-Index: 35
Last. Susan R. Davis (Monash University)H-Index: 68
view all 5 authors...
Summary Background The benefits and risks of testosterone treatment for women with diminished sexual wellbeing remain controversial. We did a systematic review and meta-analysis to assess potential benefits and risks of testosterone for women. Methods We searched MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, and Web of Science for blinded, randomised controlled trials of testosterone treatment of at least 12 weeks' duration completed between Jan 1, 1990, and Dec 10, 2018. ...
3 CitationsSource
#1Jo Marsden (University of Cambridge)H-Index: 6
In women at population risk of breast cancer (i.e. most), short-term exposure to hormone replacement therapy (i.e. up to five years’ use) for symptom relief exceeds its potential harms, including t...
2 CitationsSource
#1Midhun SomanH-Index: 1
#2Li-Cong HuangH-Index: 1
Last. Xiao-Ming ZhuH-Index: 13
view all 10 authors...
Objective: This meta-analysis aims to investigate serum androgen profiles (testosterone, dehydroepiandrosterone sulfate, androstenedione, and sex hormone-binding globulin) in women with premature ovarian failure and to establish if there is evidence of diminished androgen levels in these women. Methods: Various Internet sources of PubMed, Cochrane library, and Medline were searched systematically until February, 2018. Out of a pool of 2,461 studies, after applying the inclusion/exclusion criteri...
2 CitationsSource
#1Ritika GeraH-Index: 1
#2Salim TayehH-Index: 1
Last. Kefah MokbelH-Index: 34
view all 4 authors...
2 CitationsSource
#1Abdulmaged M. Traish (BU: Boston University)H-Index: 51
#2Linda Vignozzi (UniFI: University of Florence)H-Index: 50
Last. Noel N. KimH-Index: 38
view all 5 authors...
Abstract Introduction Genitourinary conditions in women increase in prevalence with age. Androgens are prerequisite hormones of estrogen biosynthesis, are produced in larger amounts than estrogens in women, and decrease throughout adulthood. However, research and treatment for genitourinary complaints have traditionally focused on estrogens to the exclusion of other potential hormonal influences. Aim To summarize and evaluate the evidence that androgens are important for maintaining genitourinar...
18 CitationsSource
#1James A. Simon (GW: George Washington University)H-Index: 37
#2Irwin GoldsteinH-Index: 76
Last. Linda Vignozzi (UniFI: University of Florence)H-Index: 50
view all 14 authors...
AbstractObjective:The objective of this consensus document is to broaden the perspective on clinical management of genitourinary syndrome of menopause to include androgens.Methods:A modified Delphi method was used to reach consensus among the 14 international panelists representing multiple discipli
15 CitationsSource
#1Anita H. Clayton (UVA: University of Virginia)H-Index: 40
#2Irwin GoldsteinH-Index: 76
Last. Richard Sadovsky (SUNY Downstate Medical Center)H-Index: 22
view all 17 authors...
Abstract The International Society for the Study of Women's Sexual Health process of care (POC) for management of hypoactive sexual desire disorder (HSDD) algorithm was developed to provide evidence-based guidelines for diagnosis and treatment of HSDD in women by health care professionals. Affecting 10% of adult females, HSDD is associated with negative emotional and psychological states and medical conditions including depression. The algorithm was developed using a modified Delphi method to re...
22 CitationsSource
#1Lina SchifferH-Index: 7
#2Punith KempegowdaH-Index: 3
Last. Michael W O’Reilly (University Hospitals Birmingham NHS Foundation Trust)H-Index: 1
view all 4 authors...
23 CitationsSource
Cited By0